Table 1.
Baseline Characteristics among participants randomly selected to undergo an alcohol or placebo infusion
| Alcohol (N=50) | Placebo (N=50) | P value | |
|---|---|---|---|
| Mean Age (years) | 58.78 ± 11.27 | 61.14 ± 13.08 | 0.34 |
| Female | 14 (28%) | 12 (24%) | 0.65 |
| Race | 0.69 | ||
| White | 44 (88%) | 45 (90%) | |
| African American | 2 (4%) | 1 (2%) | |
| Asian/Pacific Islander | 3 (6%) | 4 (8%) | |
| Other | 1 (2%) | 0 (0%) | |
| Hispanic ethnicity | 1 (2%) | 0 (0%) | 0.31 |
| Body Mass Index (kg/m2) | 27.38 ± 7.47 | 28.19 ± 6.79 | 0.65 |
| History of smoking | 15 (30%) | 19 (38%) | 0.40 |
| Median Pack Years (IQR) | 15 (3–20) | 0.051 | |
| Hypertension | 17 (34%) | 25 (50%) | 0.11 |
| Diabetes | 2 (4%) | 11 (22%) | 0.0074 |
| Coronary artery disease | 1 (2%) | 4 (8%) | 0.17 |
| Congestive heart failure | 2 (4%) | 4 (8%) | 0.40 |
| Stroke | 0 (0%) | 2 (4%) | 0.15 |
| Transient Ischemic Attack | 1 (2%) | 0 (0%) | 0.31 |
| Paroxysmal Atrial Fibrillation | 46 (92%) | 44 (88%) | 0.51 |
| Prior Ablation | 22 (44%) | 20 (40%) | 0.69 |
| Prior Atrial Fibrillation Ablation | 11 (22%) | 18 (36%) | 0.0051 |